← Leaderboards
William Edward Balch
Scripps Research Institute, The
$38,266,165
Attributed
$42,057,441
Total exposure
23
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$42,057,441 · 23
By mechanism
R01$34,581,875 · 11
P01$5,032,107 · 3
R21$1,252,790 · 3
RC2$1,096,941 · 1
P41$93,728 · 5
Top collaborators
- John R Riordan7 shared
- John Robert Yates5 shared
- Andrew G. Dillin2 shared
- Jeffery W Kelly2 shared
- Richard I. Morimoto2 shared
- Rockland L Wiseman2 shared
- Juliana J Conkright1 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- John Robert Yates$49,942,444
- Juliana J Conkright$107,540
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsCellsPathway InteractionsResponseMolecularLinkProtein FoldingAffectTraffickingEnvironmentBaseBiologyBiochemicalCystic FibrosisBiologicalInsightFundingProgramsComplexSignal PathwayStructureMembraneEquilibriumMolecular Chaperones
Grant awards (102)
Managing Alpha-1-Antitrypsin Deficiency (AATD) through Proteostasis Signaling Pathways$873,157
R01 · FY2025 · HL · contact PI
Modulation of Lung Disease by Genetic/Epigenetic Profiling$460,000
R01 · FY2025 · HL · contact PI
Applying Spatial Covariance to Understand Human Variation in Genetic Disease$460,000
R01 · FY2025 · HL · contact PI
Using Genetic Diversity to Manage Neurological Disease$450,800
R01 · FY2025 · AG · contact PI
Managing Alpha-1-Antitrypsin Deficiency (AATD) through Proteostasis Signaling Pathways$886,144
R01 · FY2024 · HL · contact PI
Applying Spatial Covariance to Understand Human Variation in Genetic Disease$460,000
R01 · FY2024 · HL · contact PI
Modulation of Lung Disease by Genetic/Epigenetic Profiling$452,500
R01 · FY2024 · HL · contact PI
Using Genetic Diversity to Manage Neurological Disease$452,500
R01 · FY2024 · AG · contact PI
Using Genetic Diversity to Manage Neurological Disease$452,500
R01 · FY2023 · AG · contact PI
Modulation of Lung Disease by Genetic/Epigenetic Profiling$452,500
R01 · FY2023 · HL · contact PI
Applying Spatial Covariance to Understand Human Variation in Genetic Disease$452,500
R01 · FY2023 · HL · contact PI
Using Genetic Diversity to Manage Neurological Disease$449,077
R01 · FY2023 · AG · contact PI
Modulation of Lung Disease by Genetic/Epigenetic Profiling$483,750
R01 · FY2022 · HL · contact PI
Using Genetic Diversity to Manage Neurological Disease$443,750
R01 · FY2022 · AG · contact PI
Managing the Folding Landscape in Alpha1 Liver-Lung Disease$483,750
R01 · FY2021 · HL · contact PI
Modulation of Lung Disease by Genetic/Epigenetic Profiling$483,750
R01 · FY2021 · HL · contact PI
Using Genetic Diversity to Manage Neurological Disease$443,750
R01 · FY2021 · AG · contact PI
Restoration of mutant CFTR stability and function$622,761
R01 · FY2020 · DK · contact PI
Modulation of Lung Disease by Genetic/Epigenetic Profiling$483,750
R01 · FY2020 · HL · contact PI
Managing the Folding Landscape in Alpha1 Liver-Lung Disease$483,750
R01 · FY2020 · HL · contact PI
Monitoring the aging lung using genomics, proteomics and informatics$389,816
P01 · FY2020 · AG · contact PI
Restoration of mutant CFTR stability and function$622,761
R01 · FY2019 · DK · contact PI
Monitoring the Aging Lung Through Proteomics and Quantum Imaging$543,863
P01 · FY2019 · AG · contact PI
Managing the Folding Landscape in Alpha1 Liver-Lung Disease$483,750
R01 · FY2019 · HL · contact PI
Modulation of Lung Disease by Genetic/Epigenetic Profiling$483,750
R01 · FY2019 · HL · contact PI
Restoration of mutant CFTR stability and function$622,761
R01 · FY2018 · DK · contact PI
Monitoring the Aging Lung Through Proteomics and Quantum Imaging$543,863
P01 · FY2018 · AG · contact PI
Managing the Folding Landscape in Alpha1 Liver-Lung Disease$483,750
R01 · FY2018 · HL · contact PI
Restoration of mutant CFTR stability and function$409,937
R01 · FY2018 · DK · contact PI
Restoration of mutant CFTR stability and function$646,137
R01 · FY2017 · DK · contact PI
Monitoring the Aging Lung Through Proteomics and Quantum Imaging$629,153
P01 · FY2017 · AG · contact PI
Epigenomic Modulation of Cystic Fibrosis$481,250
R01 · FY2017 · HL · contact PI
Monitoring the Aging Lung Through Proteomics and Quantum Imaging$543,863
P01 · FY2016 · AG · contact PI
Epigenomic Modulation of Cystic Fibrosis$481,250
R01 · FY2016 · HL · contact PI
Restoration of mutant CFTR stability and function$445,200
R01 · FY2016 · DK
Monitoring the Aging Lung Through Proteomics and Quantum Imaging$557,488
P01 · FY2015 · AG · contact PI
Epigenomic Modulation of Cystic Fibrosis$466,643
R01 · FY2015 · HL · contact PI
Restoration of mutant CFTR stability and function$445,200
R01 · FY2015 · DK
Epigenomic Modulation of Cystic Fibrosis$473,750
R01 · FY2014 · HL · contact PI
Proteomic Profiling of CFTR Protein Interaction$460,602
R01 · FY2014 · HL
Restoration of mutant CFTR stability and function$445,200
R01 · FY2014 · DK
The Role of Mia2 in Lipoprotein Biogenesis$232,138
R21 · FY2014 · HL · contact PI
Proteomic Profiling of CFTR Protein Interaction$447,442
R01 · FY2013 · HL
Epigenomic Modulation of Cystic Fibrosis$447,442
R01 · FY2013 · HL · contact PI
Restoration of mutant CFTR stability and function$429,619
R01 · FY2013 · DK
TRAFFICKING AND ABETA AGGREGATION$348,598
P01 · FY2013 · AG · contact PI
The Role of Mia2 in Lipoprotein Biogenesis$270,606
R21 · FY2013 · HL · contact PI
Epigenomic Modulation of Cystic Fibrosis$470,003
R01 · FY2012 · HL · contact PI
Proteomic Profiling of CFTR Protein Interaction$470,003
R01 · FY2012 · HL
Restoration of mutant CFTR stability and function$463,527
R01 · FY2012 · DK
Hsp90 Dependent Rab Tethering$411,436
R01 · FY2012 · GM · contact PI
TRAFFICKING AND ABETA AGGREGATION$368,839
P01 · FY2012 · AG · contact PI
Proteomic Profiling of CFTR Protein Interaction$474,750
R01 · FY2011 · HL
Epigenomic Modulation of Cystic Fibrosis$474,750
R01 · FY2011 · HL · contact PI
Assembly and Disassembly of COPII Nanocages$432,553
R01 · FY2011 · GM · contact PI
Hsp90 Dependent Rab Tethering$411,436
R01 · FY2011 · GM · contact PI
TRAFFICKING AND ABETA AGGREGATION$368,788
P01 · FY2011 · AG · contact PI
Sensing Protein Folding Capacity in the Cell During Aging$584,669
RC2 · FY2010 · AG · contact PI
Proteomic Profiling of CFTR Protein Interaction$474,750
R01 · FY2010 · HL
Epigenomic Modulation of Cystic Fibrosis$474,750
R01 · FY2010 · HL · contact PI
Assembly and Disassembly of COPII Nanocages$436,923
R01 · FY2010 · GM · contact PI
Hsp90 Dependent Rab Tethering$415,591
R01 · FY2010 · GM · contact PI
TRAFFICKING AND ABETA AGGREGATION$372,516
P01 · FY2010 · AG · contact PI
Sensing Protein Folding Capacity in the Cell During Aging$512,272
RC2 · FY2009 · AG · contact PI
Assembly and Disassembly of COPII Nanocages$441,336
R01 · FY2009 · GM · contact PI
Hsp90 Dependent Rab Tethering$419,789
R01 · FY2009 · GM · contact PI
TRAFFICKING AND ABETA AGGREGATION$365,320
P01 · FY2009 · AG · contact PI
Protein Homeostasis in AL Amyloidosis$232,691
R21 · FY2009 · AG · contact PI
HTS Approach to Correction of Alpha-1-Antitrypsin Misfolding Disease$215,080
R21 · FY2009 · NS · contact PI
STRUCTURE OF COPII COATED VESICLES$1,285
P41 · FY2009 · RR · contact PI
Assembly and Disassembly of COPII Nanocages$441,336
R01 · FY2008 · GM · contact PI
Protein Homeostasis in AL Amyloidosis$302,275
R21 · FY2008 · AG · contact PI
Structure and Function of GDI$121,883
R01 · FY2008 · GM · contact PI
STRUCTURE OF COPII COATED VESICLES$25,252
P41 · FY2008 · RR · contact PI
Structure and Function of Guanine Nucleotide Dissociation Inhibitor$362,177
R01 · FY2007 · GM · contact PI
GTPAse Regulation of ER Export$136,516
R01 · FY2007 · GM · contact PI
STRUCTURE OF COPII COATED VESICLES$35,779
P41 · FY2007 · RR · contact PI
HSP90 COCHAPERONE AHA1 DOWNREGULATION RESCUES MISFOLDING OF CFTR IN CYSTIC FIBRO$6,224
P41 · FY2007 · RR · contact PI
GTPAse Regulation of ER Export$412,401
R01 · FY2006 · GM · contact PI
Structure and Function of GDI$372,994
R01 · FY2006 · GM · contact PI
Function of a-1-Antitrypsin Receptor in Lung Disease$320,757
R01 · FY2006 · HL · contact PI
STRUCTURE OF COPII COATED VESICLES$25,188
P41 · FY2006 · RR · contact PI
GTPAse Regulation of ER Export$422,325
R01 · FY2005 · GM
Structure and Function of GDI$381,970
R01 · FY2005 · GM
Function of a-1-Antitrypsin Receptor in Lung Disease$328,475
R01 · FY2005 · HL
PHYSIOLOGY OF RETINAL DEGENERATION IN CHOROIDEREMIA$310,275
R01 · FY2005 · EY
GTPAse Regulation of ER Export$422,325
R01 · FY2004 · GM
Structure and Function of GDI$381,970
R01 · FY2004 · GM
Function of a-1-Antitrypsin Receptor in Lung Disease$328,475
R01 · FY2004 · HL
PHYSIOLOGY OF RETINAL DEGENERATION IN CHOROIDEREMIA$310,275
R01 · FY2004 · EY
GTPAse Regulation of ER Export$422,325
R01 · FY2003 · GM
STRUCTURE AND FUNCTION OF GDI$340,168
R01 · FY2003 · GM
Function of a-1-Antitrypsin Receptor in Lung Disease$328,475
R01 · FY2003 · HL
PHYSIOLOGY OF RETINAL DEGENERATION IN CHOROIDEREMIA$310,275
R01 · FY2003 · EY
GTPASE REGULATION OF ER EXPORT$421,193
R01 · FY2002 · GM
STRUCTURE AND FUNCTION OF GDI$337,926
R01 · FY2002 · GM
PHYSIOLOGY OF RETINAL DEGENERATION IN CHOROIDEREMIA$310,275
R01 · FY2002 · EY
GTPASE REGULATION OF ER EXPORT$392,740
R01 · FY2001 · GM
PHYSIOLOGY OF RETINAL DEGENERATION IN CHOROIDEREMIA$354,600
R01 · FY2001 · EY
STRUCTURE AND FUNCTION OF GDI$323,683
R01 · FY2001 · GM
GTPASE REGULATION OF ER EXPORT$383,680
R01 · FY2000 · GM
STRUCTURE AND FUNCTION OF GDI$323,651
R01 · FY2000 · GM